What can we learn from the public's understanding of drug information and safety? A population survey

The International Journal of Pharmacy Practice
Esther SalgueiroGloria Manso

Abstract

The aim of our study was to analyse the perceptions of the public on medicine information and safety and on consumer reporting of suspected adverse drug reactions (ADR). A voluntary survey was conducted in a population ≥18 years of age in Asturias, a region in northern Spain. The survey was designed to be completed in a face-to-face street interview or completed independently by the public. The survey consisted of structured questions organised in four sections: (1) demographic data, (2) use of medicines, (3) reading and understanding of the patient information leaflet (PIL) and (4) awareness and perception about consumer reporting of ADR. A total of 402 surveys were given and analysed; 295 were completed independently and 107 were completed in street interviews. Of the population surveyed, 82.3% had taken some drug(s) in the previous 3 months, although only 62.4% had performed so by medical prescription. A quarter of respondents claimed that they never read the PIL of medicines, 12.7% that they sometimes read it, and 61.4% that they always read this information. A high percentage (82.8%) of respondents reported that they were not aware of consumer reporting of ADR, and 86.1% stated their agreement with this option. The public ...Continue Reading

References

May 3, 2005·Pharmacy World & Science : PWS·Jan GustafssonJ Lars G Nilsson
Sep 19, 2006·Atencion primaria·Albert J JovellSergi Blancafort
Feb 6, 2007·British Journal of Clinical Pharmacology·A BlenkinsoppP A Routledge
Apr 5, 2007·The Annals of Pharmacotherapy·Joseph P NathanJack M Rosenberg
Mar 28, 2008·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Neil CarriganPeter Knapp
Mar 12, 2010·The New England Journal of Medicine·Ethan Basch
Jul 27, 2010·European Journal of Clinical Pharmacology·Florence van HunselKees van Grootheest
Feb 18, 2011·Pharmacoepidemiology and Drug Safety·David J McLernonUNKNOWN Yellow Card Study Collaboration
Apr 19, 2011·British Journal of Clinical Pharmacology·Claire AndersonUNKNOWN Yellow Card Study Collaboration
Apr 28, 2011·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Claire AndersonUNKNOWN Yellow Card Study Collaboration
Aug 3, 2011·Pharmacoepidemiology and Drug Safety·Janet KrskaCraig Wilson
Jan 14, 2012·Theoretical Medicine and Bioethics·Diego Gracia
May 24, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Janet Krska, Charles W Morecroft
Nov 19, 2013·The Medical Journal of Australia·Jane Robertson, David A Newby
Apr 22, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Florence Margraff, Delphine Bertram
Oct 9, 2014·International Journal of Clinical Pharmacology and Therapeutics·Francisco J JimenoGloria Manso
Jan 30, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Linda HärmarkBirgitta Grundmark
May 26, 2015·European Journal of Clinical Pharmacology·Cristiano MatosJoão Joaquim
Jan 13, 2016·International Journal of Clinical Pharmacology and Therapeutics·María Luisa Nicieza-GarciaGloria Manso
Sep 2, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Cristiano MatosFlorence van Hunsel
Sep 23, 2016·International Journal of Clinical Pharmacy·Mara M van BeusekomJos M van den Broek
Apr 19, 2017·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Marin BanovacPeter Arlett
May 26, 2017·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Sieta T de VriesUNKNOWN SCOPE Work Package 6

❮ Previous
Next ❯

Citations

Jun 6, 2020·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Giovanni FurlanMarco Tuccori
Nov 22, 2020·Pharmacy : Journal of Pharmacy, Education and Practice·Md Ashraful IslamSyed Azizullah Ghori

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Clinical Pharmacy
Lise Aagaard, Ebba H Hansen
Journal de pharmacie de Belgique
L LeemansS Deferme
Journal of Clinical Pharmacy and Therapeutics
H FortnumYellow Card Study Collaboration
European Journal of Clinical Pharmacology
Narumol JarernsiripornkulJanet Krska
© 2022 Meta ULC. All rights reserved